03 Feb 2025
// FDA
21 Aug 2024
// FDA
05 Aug 2024
// FDA
Latest Content by PharmaCompass
Reset all filters
01 6BREXPIPRAZOLE
02 1NITAZOXANIDE
Reset all filters
01 7ZENARA
Reset all filters
01 7TABLET;ORAL
Reset all filters
01 10.25MG
02 10.5MG
03 11MG
04 12MG
05 13MG
06 14MG
07 1500MG
Reset all filters
01 7USA
Regulatory Info :
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BREXPIPRAZOLE
Dosage Strength : 0.25MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BREXPIPRAZOLE
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BREXPIPRAZOLE
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BREXPIPRAZOLE
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BREXPIPRAZOLE
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BREXPIPRAZOLE
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : NITAZOXANIDE
Dosage Strength : 500MG
Packaging :
Approval Date : 2025-02-03
Application Number : 214844
Regulatory Info : RX
Registration Country : USA